Si queremos cumplir los hitos de la Estrategia del Fondo
Mundial para 2028 y mantener a nuestro alcance la
meta del ODS 3, necesitamos recaudar 18.000 millones
USD para financiar el próximo ciclo de subvenciones
trienal del Fondo Mundial.
Pour franchir toutes les étapes de la stratégie du
Fonds mondial jusqu’en 2028 et nous assurer que la
cible de l'ODD 3 reste à notre portée, nous devons
mobiliser 18 milliards de dollars US pour notre prochain
cycle triennal de subvention.
Dies ist ein entscheidender Moment bei der Bekämpfung von HIV, Tuberkulose (TB) und Malaria. Für unsere achte Wiederauffüllung benötigt der Globale Fonds 18 Milliarden US-Dollar, um 23 Millionen Menschenleben zu retten, die Sterberate der drei Krankheiten um 64 % zu senken und am Aufbau einer We...lt mitzuwirken, die gesünder, sicherer und gerechter ist.
more
Estamos en un momento decisivo de la lucha contra el VIH, la tuberculosis y la malaria. El Fondo Mundial necesita recaudar 18.000 millones USD en la Octava Reposición de Recursos para salvar 23 millones de vidas, reducir en un 64% la tasa de mortalidad de las tres enfermedades, y ayudar a construir... un mundo más saludable, seguro y equitativo.
more
Nous sommes à un moment crucial de la lutte contre le VIH, la tuberculose et le paludisme. Pour sa huitième reconstitution des ressources, le Fonds mondial a besoin de 18 milliards de dollars US pour sauver 23 millions de vies, réduire le taux de mortalité des trois maladies de 64 % et bâtir un... monde en meilleure santé, plus sûr et plus équitable.
more
Private sector engagement opens pathways for a game-changing US$2 billion investment opportunity in the fight against HIV, tuberculosis and malaria.
The motivations behind China’s allocation of health aid to Africa remain complex due to limited information on the details of health aid project activities. Insufficient knowledge about the purpose of China’s health aid hinders our understanding of China’s comprehensive role in supporting Afri...ca’s healthcare system. To address this gap, our study aimed to gain better insights into China’s health aid priorities and the factors driving these priorities across Africa. To achieve this, we utilized AidData’s Chinese Official Finance Dataset and adhered to the Organisation for Economic Co-operation and Development (OECD) guidelines.
more
Strengthening resilient and sustainable systems for health (RSSH) is central to the Global Fund’s strategy, however questions persist about the Global Fund’s role in the health systems strengthening space, and the extent to which investments are designed to achieve strengthening objectives, or j...ust fill in gaps in the system. This paper reports on findings from the Prospective Country Evaluations (PCE), a multi-country multi-year evaluation of Global Fund support.
more
The COVID-19 pandemic disrupted health systems in 2020, but it is unclear how financial hardship due to out-of-pocket (OOP) health-care costs was affected. We analysed catastrophic health expenditure (CHE) in 2020 in
five countries with available household expenditure data: Belarus, Mexico, Peru, R...ussia, and Viet Nam. In Mexico and Peru, we also conducted an analysis of drivers of change in CHE in 2020 using publicly available data.
more
The relative priority received by issues
in global health agendas is subjected to impressionistic
claims in the absence of objective methods of assessment
of priority. To build an approach for conducting structured
assessments of comparative priority health issues receive,
we expand the public ...arenas model (2021) and offer a
framework for future assessments of health issue priority
in global and national health agendas.
more
When we presented our analysis of Germany’s role in
global health in 2017 at an event in Berlin, Richard
Horton, the Editor-in-Chief of The Lancet, asked only
half-jokingly whether we could expect Germany to finally
shrug off the habitus of the “reluctant leader” and “step
up”. Back t...hen, the entire team of authors were hesitant
to use the term leadership as a broad label. We decided to
highlight areas where leadership could be observed, but
refrained from using it in the title of our previous study.
7 years later, after a devastating global pandemic, notable
political changes in Germany, and amid a substantially
changed global health landscape, we aim to analyse
Germany’s role in global health once more.
more
Covid-19 has reinforced health and economic cases for investing in pandemic preparedness and response (PPR). The World Bank and World Health Organization (WHO) propose that low- and middle-income
governments and donor countries should invest $31.1 billion each year for PPR. We analyse, based on the... projected economic growth of countries between 2022 and 2027, how likely it is that low- and middle-income country governments and donors can mobilize the estimated funding.
more
The UK could regain its leadershipin the provision of development assistance for healthunder the next government. But this doesn’t seem likely if the party manifestos are any guide.
Dieses Dokument stellt aktuelle Ergebnisse zum Thema Official Development Assistance (ODA) mit Fokus auf Gesundheit und Deutschland zur Verfügung.
Background
Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul...d be used for analyses from both donor and recipient perspectives. Muskoka2 was developed to meet these needs. We describe Muskoka2 and present estimates of levels and trends in aid for RMNCH in 2002–17, with a focus on the latest estimates for 2017.
Methods
Muskoka2 is an automated algorithm that generates disaggregated estimates of aid for reproductive health, maternal and newborn health, and child health at the global, donor, and recipient-country levels. We applied Muskoka2 to the Organisation for Economic Co-operation and Development's Creditor Reporting System (CRS) aid activities database to generate estimates of RMNCH disbursements in 2002–17. The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. We analysed funding by donor for the 20 largest donors, by recipient-country income group, and by recipient for the 16 countries with the greatest RMNCH need, defined as the countries with the worst levels in 2015 on each of seven health indicators.
Findings
After 3 years of stagnation, reported aid for RMNCH reached $15·9 billion in 2017, the highest amount ever reported. Among donors reporting in both 2016 and 2017, aid increased by 10% ($1·4 billion) to $15·4 billion between 2016 and 2017. Child health received almost half of RMNCH disbursements in 2017 (46%, $7·4 billion), followed by reproductive health (34%, $5·4 billion), and maternal and newborn health (19%, $3·1 billion). The USA ($5·8 billion) and the UK ($1·6 billion) were the largest bilateral donors, disbursing 46% of all RMNCH funding in 2017 (including shares of their core contributions to multilaterals). The Global Fund and Gavi were the largest multilateral donors, disbursing $1·7 billion and $1·5 billion, respectively, for RMNCH from their core budgets. The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% in 2017. Nigeria received 7% ($1·1 billion) of all aid for RMNCH in 2017, followed by Ethiopia (6%, $876 million), Kenya (5%, $754 million), and Tanzania (5%, $751 million).
Interpretation
Muskoka2 retains the speed, transparency, and donor buy-in of the G8's previous Muskoka approach and incorporates eight innovations to improve precision. Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience substantial funding gaps and threats to future funding. Maternal and newborn health receives considerably less funding than reproductive health or child health, which is a persistent issue requiring urgent attention.
Funding
Bill & Melinda Gates Foundation; Partnership for Maternal, Newborn & Child Health.
more
Dieses Dokument bietet eine Problemanalyse der US-Kürzungen im Bereich globale Gesundheit und leitet daraus konkrete Handlungsempfehlungen für medizinische Akteure ab. Im Fokus steht die Analyse der direkten Auswirkungen auf die gesundheitsspezifische Entwicklungszusammenarbeit.
Diese zweiseitige Kurzfassung bietet eine Problemanalyse der US-Kürzungen im Bereich globale Gesundheit und leitet daraus konkrete Handlungsempfehlungen für medizinische Akteure ab. Im Fokus steht die Analyse der direkten Auswirkungen auf die gesundheitsspezifische Entwicklungszusammenarbeit.
This publication provides a problem analysis of the U.S. cuts in global health and derives concrete recommendations for action for medical actors. The focus is on analyzing the direct effects on health-specific development cooperation.
Diese Publikation erklärt anhand von Grafiken die Wichtigkeit von Entwicklungszusammenarbeit im Allgemeinen und für Gesundheit im Speziellen. Denn finanzielle Beiträge im Rahmen der Entwicklungszusammenarbeit haben sich in den letzten Jahrzehnten als unerlässlich, wirksam, günstig und verantwor...tungsvoll erwiesen.
more
Trends in development assitance for health